Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

TransMedics (TMDX) Other Operating Expenses (2018 - 2023)

TransMedics has reported Other Operating Expenses over the past 2 years, most recently at $27.2 million for Q3 2023.

  • Quarterly results put Other Operating Expenses at $27.2 million for Q3 2023, changed N/A from a year ago — trailing twelve months through Jun 2024 was $27.2 million (changed N/A YoY), and the annual figure for FY2023 was $27.2 million, changed.
  • Other Operating Expenses for Q3 2023 was $27.2 million at TransMedics, up from $13.7 million in the prior quarter.
  • Over the last five years, Other Operating Expenses for TMDX hit a ceiling of $27.2 million in Q3 2023 and a floor of $27.2 million in Q3 2023.